Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biofield was a U.S. medical technology company focused on noninvasive diagnostic devices, with its lead product the Biofield Breast Diagnostic System (BDS) for assisting in breast cancer detection. Public disclosures described the company as a development-stage issuer and a medical technology company pursuing commercialization of diagnostic technology in large population markets. The business appears to have centered on licensing, developing, and distributing the BDS rather than building a broad therapeutic drug pipeline. Historical records also show the company later operated under the name MacKay Life Sciences for a period. Based on the available evidence, Biofield appears to be an inactive former OTC-listed diagnostics company rather than an active biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofield Corporation.